SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evaxion begins applying AI-Immunology™ platform to autoimmune diseases

Evaxion says it has begun applying its AI-Immunology™ platform to autoimmune diseases, expanding its therapeutic focus.

EVAX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.